T. Rowe Price Investment Management, Inc. Avanos Medical, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,996,518 shares of AVNS stock, worth $43.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,996,518
Previous 3,757,576
6.36%
Holding current value
$43.1 Million
Previous $53.8 Million
9.15%
% of portfolio
0.03%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding AVNS
# of Institutions
309Shares Held
44.5MCall Options Held
0Put Options Held
21.8K-
Black Rock Inc. New York, NY7.01MShares$75.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$48.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.58MShares$27.8 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.04MShares$22 Million0.44% of portfolio
-
State Street Corp Boston, MA1.92MShares$20.7 Million0.0% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $502M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...